These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25052705)

  • 21.
    da Silva PFF; Goveia RM; Teixeira TB; Gamba BF; de Lima AP; Rogatto SR; Silveira-Lacerda EP
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625568
    [No Abstract]   [Full Text] [Related]  

  • 22. Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
    Mastellaro MJ; Seidinger AL; Kang G; Abrahão R; Miranda ECM; Pounds SB; Cardinalli IA; Aguiar SS; Figueiredo BC; Rodriguez-Galindo C; Brandalise SR; Yunes JA; Barros-Filho AA; Ribeiro RC
    Cancer; 2017 Aug; 123(16):3150-3158. PubMed ID: 28387921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation.
    Andrade KC; Santiago KM; Fortes FP; Mambelli LI; Nóbrega AF; Achatz MI
    Genet Mol Biol; 2016 May; 39(2):199-202. PubMed ID: 27223487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MIR605 rs2043556 is associated with the occurrence of multiple primary tumors in TP53 p.(Arg337His) mutation carriers.
    Bandeira IC; Vieira IA; Andreis TF; Brussa Reis L; Macedo GS; Vianna FSL; Santos-Silva P; Palmero EI; Galvão HCR; Ramos CRN; Santiago KM; Achatz MI; da Costa AABA; Ashton-Prolla P
    Cancer Genet; 2020 Jan; 240():54-58. PubMed ID: 31778928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.
    Cury NM; Ferraz VE; Silva WA
    Hered Cancer Clin Pract; 2014 Mar; 12(1):8. PubMed ID: 24625245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53 mutation p.R337H in gastric cancer tissues of a 12-year-old male child: evidence for chimerism involving a common mutant founder haplotype: case report.
    da Silva EM; Achatz MI; Martel-Planche G; Montagnini AL; Olivier M; Prolla PA; Hainaut P; Soares FA
    BMC Cancer; 2011 Oct; 11():449. PubMed ID: 22004116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).
    Petry V; Bonadio RC; Cagnacci AQC; Senna LAL; Campos RDNG; Cotti GC; Hoff PM; Fragoso MCBV; Estevez-Diz MDP
    Fam Cancer; 2020 Jan; 19(1):47-53. PubMed ID: 31748977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
    Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
    Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Inherited p53 Mutation in the Brazilian Population.
    Achatz MI; Zambetti GP
    Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27663983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Brazilian TP53 mutation (R337H) and sarcomas.
    Volc SM; Ramos CRN; Galvão HCR; Felicio PS; Coelho AS; Berardineli GN; Campacci N; Sabato CDS; Abrahao-Machado LF; Santana IVV; Campanella N; Lengert AVH; Vidal DO; Reis RM; Dantas CF; Coelho RC; Boldrini E; Serrano SV; Palmero EI
    PLoS One; 2020; 15(1):e0227260. PubMed ID: 31978118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors.
    Feitosa JADS; das Chagas PF; de Sousa GR; Queiroz RGP; Cruzeiro GAV; Tone LG; Borges KS; Valera ET
    Mol Biol Rep; 2020 Aug; 47(8):6439-6443. PubMed ID: 32671623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation.
    Figueiredo BC; Sandrini R; Zambetti GP; Pereira RM; Cheng C; Liu W; Lacerda L; Pianovski MA; Michalkiewicz E; Jenkins J; Rodriguez-Galindo C; Mastellaro MJ; Vianna S; Watanabe F; Sandrini F; Arram SB; Boffetta P; Ribeiro RC
    J Med Genet; 2006 Jan; 43(1):91-6. PubMed ID: 16033918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
    Palmero EI; Schüler-Faccini L; Caleffi M; Achatz MI; Olivier M; Martel-Planche G; Marcel V; Aguiar E; Giacomazzi J; Ewald IP; Giugliani R; Hainaut P; Ashton-Prolla P
    Cancer Lett; 2008 Mar; 261(1):21-5. PubMed ID: 18248785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.
    Hahn EC; Bittar CM; Vianna FSL; Netto CBO; Biazús JV; Cericatto R; Cavalheiro JA; de Melo MP; Menke CH; Rabin E; Leistner-Segal S; Ashton-Prolla P
    PLoS One; 2018; 13(12):e0209934. PubMed ID: 30596752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma.
    de Almeida Magalhães T; Borges KS; de Sousa GR; Brandalise SR; Seidinger AL; Scrideli CA; Oba-Shinjo SM; Yunes JA; Tone LG
    Neurol Sci; 2020 Mar; 41(3):691-694. PubMed ID: 31728854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
    Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
    Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil.
    Custodio G; Taques GR; Figueiredo BC; Gugelmin ES; Oliveira Figueiredo MM; Watanabe F; Pontarolo R; Lalli E; Torres LF
    PLoS One; 2011 Mar; 6(3):e18015. PubMed ID: 21445348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal leiomyosarcoma as the initial phenotypic manifestation of Li-Fraumeni-like syndrome: a case report and review of the literature.
    Severino NP; Waisberg J; Fragoso MCBV; de Lima LGCA; Balsamo F; Henriques AC; Bianco B; de Sousa Gehrke F
    J Med Case Rep; 2022 Dec; 16(1):468. PubMed ID: 36529791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.
    Fortes FP; Kuasne H; Marchi FA; Miranda PM; Rogatto SR; Achatz MI
    Braz J Med Biol Res; 2015 Jul; 48(7):610-5. PubMed ID: 25945745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What 20 years of research has taught us about the TP53 p.R337H mutation.
    Pinto EM; Zambetti GP
    Cancer; 2020 Nov; 126(21):4678-4686. PubMed ID: 32875577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.